Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
US Stock MarketDetailed Quotes
ESLA Estrella Immunopharma
- 0.8800
- -0.0600-6.38%
Close Apr 4 16:00 ET
- 0.8800
- 0.00000.00%
Post 16:05 ET
31.83MMarket Cap-3.61P/E (TTM)
0.9900High0.8234Low25.01KVolume0.9200Open0.9400Pre Close22.99KTurnover0.25%Turnover RatioLossP/E (Static)36.17MShares3.230052wk High220.00P/B8.73MFloat Cap0.630052wk Low--Dividend TTM9.93MShs Float33.0000Historical High--Div YieldTTM17.72%Amplitude0.6300Historical Low0.9190Avg Price1Lot Size
Estrella Immunopharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q1)Sep 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -133.03%-3.11M | -705.79%-2.22M | -574.10%-291.51K | -4,914.13%-4.23M | -10,313.48%-11.27M | 74.99%-275.19K | 7.34%-1.34M | 95.33%-43.25K | 21.30%-84.45K | -108.2K |
| Net income from continuing operations | 60.17%-4.43M | -80.53%-3.38M | -44.65%-3.95M | 82.87%-469.53K | 62.97%-1.02M | 35.17%-1.87M | -559.47%-11.11M | -154.29%-2.73M | -1,528.78%-2.74M | ---2.76M |
| Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.49K | ---- |
| Change In working capital | -90.59%881.25K | 189.35%1.16M | 40.73%3.66M | -247.72%-3.77M | -503.91%-10.25M | -76.19%400.65K | 8,165.20%9.37M | 2,194.06%2.6M | --2.55M | --2.54M |
| -Change in prepaid assets | -332.21%-1.94M | ---1.65M | 7,134.70%3.62M | -6,909.72%-3.5M | ---262.48K | --0 | 200.00%833.33K | 106.00%50K | ---50K | --0 |
| -Change in payables and accrued expense | -67.00%2.82M | 600.90%2.81M | -98.35%42.21K | -110.02%-260.24K | -493.66%-9.98M | -52.81%400.65K | 801.61%8.54M | 169.56%2.55M | --2.6M | --2.54M |
| -Change in other current liabilities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --512 | --585 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -133.03%-3.11M | -705.79%-2.22M | -574.10%-291.51K | -4,914.13%-4.23M | -10,313.48%-11.27M | 74.99%-275.19K | 7.34%-1.34M | 95.33%-43.25K | 21.30%-84.45K | ---108.2K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 5.07M | -112.3K | -273.07K | -136.53K | -136.53K | 0 |
| Net other investing changes | ---- | ---- | --0 | --0 | --5.07M | ---112.3K | ---273.07K | ---136.53K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --5.07M | ---112.3K | ---273.07K | ---136.53K | ---136.53K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -134.99K | -100.75%-150.47K | -270.35K | -84.09K | -6.9M | 20.05M | 0 | 0 | 0 | 0 |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | ---300K | --300K | --0 | --0 | --0 | --0 |
| Net common stock issuance | ---134.99K | ---150.47K | ---270.35K | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net preferred stock issuance | --0 | --0 | --0 | --0 | --0 | --9.02M | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | --0 | --0 | ---6.6M | --10.73M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---134.99K | -100.75%-150.47K | ---270.35K | ---84.09K | ---6.9M | --20.05M | --0 | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 1.89%4.17M | 68.02%4.17M | 77.79%4.73M | 214.11%9.05M | 640.87%22.14M | -39.36%2.48M | --4.09M | --2.66M | --2.88M | --2.99M |
| Current changes in cash | -101.87%-3.25M | -112.05%-2.37M | -212.53%-561.86K | -1,854.29%-4.32M | -12,000.24%-13.09M | 1,886.80%19.66M | ---1.61M | -104.40%-179.78K | ---220.99K | ---108.2K |
| End cash Position | -63.01%916.92K | -91.88%1.8M | 68.02%4.17M | 77.79%4.73M | 214.11%9.05M | 640.87%22.14M | -39.36%2.48M | -39.36%2.48M | --2.66M | --2.88M |
| Free cash flow | -133.03%-3.11M | -705.79%-2.22M | -574.10%-291.51K | -4,914.13%-4.23M | -10,313.48%-11.27M | 74.99%-275.19K | 7.34%-1.34M | 95.33%-43.25K | 21.30%-84.45K | ---108.2K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now